Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Neo Board Review > MFM > Flashcards

MFM Flashcards

1
Q

When is AFP checked

A

Between 15 and 22 weeks gestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

High AFP causes

A

Open NTD
GI abn (liver necrosis, esophageal or intestinal obstruction, omphalocele, gastroschisis)
Renal abn
Masses
Multiple gestation
If unexplained elevation - ^risk of IUGR or fetal death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Low AFP causes

A

Trisomies
Fetal death
Inaccurate GA
Gestational trophoblastic disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

First trimester maternal screen

A

At 10-13 weeks
PAPP-A
B hCG
Combined with maternal age - detects 60-65% T21

+ nuchal translucency 10-14 weeks
Mat age + PAPP A + BhCG + NT detects 78-89% of T21 and 91% of T18

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Abn nuchal translucency risk of aneuploidy

A

1 in 6
Normal is 0.5mm-2mm; >3mm is abn
Explanations for nuchal translucency:
Cardiac failure
Extracellular matrix abn
Abn lymphatic system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hygroma testing

A

50% chance aneuploidy
If euploid 50% with major fetal malformation
If found -> get details US, fetal echo, offer CVS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Quadruple screen

A

14-20 weeks
AFP
Mat unconjugated estriol
BhCG
Inhibin A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Low AFP, high BhCG, low uE3, high inhibin A

A

T21 on quad
Detects 75-81%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Low AFP, low BhCG, low uE3, normal inhibin A

A

T18 quad
Detects 60%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T13 quad

A

Not helpful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cell free DNA - obtained when & indications

A

9 weeks GA
Screening test
^ aneuploidy risk
RhD genotype
Sex identification in X-linked genetic disorders
Risk of CAH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Smith-Lemli-Opitz
Prenatal screen

A

Low uE3, low AFP, low bhCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Turner syndrome quad screen

A

Low AFP, high BhCG, low uE3, high inhibin A if hydrops, low inhibin A if no hydrops

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Timing of amnio, CVS, and PUBS

A

Amnio 15-20 wk
CVS 10-13 wk
PUBS >19 wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Teratogenic effects:
ACEI

A

Greatest risk in 2nd & 3rd tri
Oligo, skull hypoplasia, renal tubular dysgenesis
Postnatal hypotension and oliguria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Teratogenic effects:
Alcohol

A

Worse earlier in gestation
Worse with greater amounts less frequently than chronic small amounts
Abn in 3 areas: physical, growth, neurodevelopment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Teratogenic effects:
Carbamazepine

A

Craniofacial defects, fingernail hypoplasia, growth restriction
NTD, developmental delay
Decreased placental transfer of vit K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Teratogenic effects:
Cocaine

A

Placental abruption
Cutis aplasia, porenchephaly, ileal atresia, cardiac abn, fetal growth restriction, GU abn

19
Q

Teratogenic effects:
Cyclophosphamide

A

Exposure early in pregnancy
Missing or hypoplastic digits, cleft palate, single coronary artery, imperforate anus, growth restriction, microcephaly

20
Q

Teratogenic effects:
Phenytoin (hydantoin)

A

Digit and nail hypoplasia, cleft lip/palate, IUGR, FTT, wide anterior fontanelle, hernias, dec placental vit K transfer, maybe cardiac abn (PS, AS, VSD)

21
Q

Teratogenic effects:
Retinoic acid

A

1st tri exposure
Cardiac: TGA, TA, TOF, VSD, DORV, IAA, retroesophageal subclavian artery
Microtia, hypertelorism, triangular facies, facial nerve palsies, limb reduction, hydrocephalus, thymic and parathyroid abn

22
Q

Teratogenic effects:
Lithium

A

Ebsteins anomaly

23
Q

Teratogenic effects:
Methotrexate

A

6-8 weeks after conception exposure
Cranial dysplasia, broad nasal bridge, low set ears, micrognathia, microcephaly, IUGR

24
Q

Teratogenic effects:
Phenobarbital

A

Cleft lip/palate, cardiac abn, decreased placental transfer of vit K

25
Q

Teratogenic effects:
Salicylates

A

Risk thrombocytopenia
Intrauterine closure of PDA, PH

26
Q

Teratogenic effects:
Valproic acid

A

NTD, long thin fingers, hyperconvex nails, narrow bifrontal diameter, anteverted nostrils, midface hypoplasia, cardiac (CoA, hypoplastic left heart, AS, IAA, ASD, PA w/IVS)

27
Q

Teratogenic effects:
Warfarin

A

Exposure 6-12 weeks GA
Nasal hypoplasia, mental deficiency, seizures, stippled bone epiphyses

Heparin does NOT cross the placenta

28
Q

Symmetric IUGR/SGA

A

HC proportional to rest of body
Early onset (prior to 3rd trimester)
Risk of perinatal depression is low
Blood flow to ICA is normal
Normal glycogen fat and glucose stores
Etiology: Usually intrinsic, results from chromosomal abnormalities, congenital infections, and some IEM

29
Q

Asymmetric IUGR/SGA

A

HC % greater than weight %
Onset 3rd trimester (but can develop between 16-32 weeks as well)
Risk of perinatal depression is increased
Blood flow to the ICA is increased (thus the brain growth is spared)
Low glycogen and fat stores so an increased risk of hypoglycemia
Etiology: usually environmental, results from uteroplacental insufficiency from preE, cHTN, or severe maternal DM

30
Q

Neonatal effects of IUGR

A

Depressed immune system (decreased lymphocyte number and function and decreased Ig levels)
Hyperglycemia (bc of low insulin and increased catecholamines)
Hypoglycemia (bc of low stores)
Hypothermia
Hypocalcemia (bc of decreased vascular supply in utero)
Perinatal depression (bc of acute on chronic stress)
Polycythemia (bc of chronic hypoxemia)
Mortality risk 5-20x greater than AGA counterpart

31
Q

Mechanism of hydrops

A

Congestive heart failure (most common)
Anemia
Lymphatic obstruction
Decreased plasma on osmotic pressure with increased capillary permeability

32
Q

Postnatal management of NI hydrops

A

See what’s been performed.

Chromosomal analysis, metabolic studies, CBC, blood type, Hb electrophoresis, skeletal X-rays, echocardiogram, US of abdomen and chest, genetics evaluation

33
Q

Range for uterine artery gas

A

7.4/32/95 sat 98%

34
Q

Range for Uterine vein gas

A

7.34/40/40 sat 76%

35
Q

Range for umbilical vein gas

A

7.35 (7.25-7.45) / 38 (26-49) / 29 (17-40) sat 68%

36
Q

Range for umbilical artery gas

A

7.28 (7.18-7.38) / 49 (32-65) / 18 (5-30) sat 30%

37
Q

Non immune fetal hydrops

A
  1. Disorders a/c CHF (most common)
  2. Anemia
  3. Obstructed lymphatic flow
  4. Decreased plasma osmotic pressure with increased capillary permeability

(Heme: TTTS, homozygous alpha thal, rbc enzyme deficiencies, severe fetomaternal hemorrhage;
Cardiac: arrhythmia, CHD, cardiac mass, cardiomyopathy;
Vascular malformation: AVM, vascular accident, lymphatic obstruction;
Infection: coxsackie, parvo, CMV, syphilis, toxo, rubella, herpes, adenovirus;
Genetic: aneuploidy, syndrome;
Metabolic: LSD, GSD type IV;
Endocrine: thyrotoxicosis;
Pulmonary: chylothorax, CPAM, pulmonary sequestration;
Other: congenital nephrotic syndrome, CDH, skeletal dysplasia, placental/coed abnormalities)

38
Q

Causes of neonatal withdrawal

A

Narcotics
Barbiturates
Stimulants
Depressants and sedatives (like alcohol)
SSRI

39
Q

Timing of symptoms narcotic withdrawal

A

Heroin within 48 hours
Methadone within 48-72 hours and symptoms can last for 4-6 months
CNS, ANS, GI, Resp symptoms

40
Q

Timing of symptoms barbiturates

A

DOL 4-7
Acute (irritable, crying, no sleep, tremors, hiccups) and subacute stage (voracious appetites, reflux, gagging, irritable, sweating, sensitive to sound, poor sleep)

41
Q

Timing of symptoms for stimulants

A

Within 72 hours
Symptoms due to drug toxicity rather and withdrawal so symptoms are stimulant symptoms

42
Q

Timing of symptoms for depressant and sedatives

A

Ethanol 3-12 hours (initial ~72 hours hyperactive and irritable and then lethargic phase for ~48 hours)
Sedative or hypnotic meds usually not until after few days

43
Q

Timing of symptoms for SSRI

A

Within 48 hours and resolve within 48 hours
Symptoms in 1/3 of neonates exposed
Tremors, hypertonic, sleep disturbance, GI disturbance, high pitched cry
Can have PH (poor neonatal adaptation)

Neo Board Review (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions